UNSPSC 51111626: Bexarotene

This classification denotes a retinoic acid agent with the molecular formula C24H28O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A61RXM4375, chemically known as 4-(1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl)benzoic acid but generally known as bexarotene, which bears US NIH Compound Identifier 82146. European Medicines Agency schedules Bexarotene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00795MIG.

UNSPSC 51111626 Bexarotene is a Commodity code for procurement of a specific pharmaceutical retinoid used to treat cutaneous T-cell lymphoma and other dermatological conditions. State and local governments procure bexarotene primarily through health departments, correctional health systems, and public hospital networks to stock formularies and meet patient treatment protocols. The drug is typically sourced through state pharmaceutical contracts, group purchasing organization agreements, or direct vendor relationships negotiated at the state or regional level. Procurement volumes and frequency depend on patient census and clinical need within each jurisdiction's public healthcare delivery system.

The source material provides no recent state and local contract opportunities under this code. Without access to active solicitations or awarded contracts naming bexarotene procurement, no geographic concentration, issuing-body mix, or representative opportunities can be characterized from current market activity.